Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralf Buettner

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Molecular Cancer Research : MCR|August 19, 2007
Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicityRalf Buettner, Mei Huang, Tanya Gritsko, et al.
Cancer Research|November 2, 2013
Loss of androgen receptor expression promotes a stem-like cell phenotype in prostate cancer through STAT3 signalingAnne Schroeder, Andreas Herrmann, Gregory Cherryholmes, et al.
Oncogene|March 1, 2005
Stat3 regulates genes common to both wound healing and cancerDaniel J Dauer, Bernadette Ferraro, Lanxi Song, et al.
Cancer Research|October 19, 2005
Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cellsSangkil Nam, Donghwa Kim, Jin Q Cheng, et al.
Translational Oncology|May 30, 2019
Increasing Antitumor Activity of JAK Inhibitor by Simultaneous Blocking Multiple Survival Signaling Pathways in Human Ovarian CancerWei Wen, Ernest S Han, Thanh H Dellinger, et al.
Plos One|November 21, 2012
Spirooxindole derivative SOID-8 induces apoptosis associated with inhibition of JAK2/STAT3 signaling in melanoma cellsYan Tian, Sangkil Nam, Lucy Liu, et al.
Cancer Biology & Therapy|August 17, 2012
A novel 7-bromoindirubin with potent anticancer activity suppresses survival of human melanoma cells associated with inhibition of STAT3 and Akt signalingLucy Liu, Marina Kritsanida, Prokopios Magiatis, et al.
Biochemical Pharmacology|September 12, 2013
3-O-methylthespesilactam, a new small-molecule anticancer pan-JAK inhibitor against A2058 human melanoma cellsMin-Yi Li, Yan Tian, Li Shen, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2005
Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cellsSangkil Nam, Ralf Buettner, James Turkson, et al.
Cancer Research|May 2, 2013
Critical role of STAT3 in IL-6-mediated drug resistance in human neuroblastomaTasnim Ara, Rie Nakata, Michael A Sheard, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Molecular Cancer Research : MCR|August 19, 2007
Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicityRalf Buettner, Mei Huang, Tanya Gritsko, et al.
Cancer Research|November 2, 2013
Loss of androgen receptor expression promotes a stem-like cell phenotype in prostate cancer through STAT3 signalingAnne Schroeder, Andreas Herrmann, Gregory Cherryholmes, et al.
Oncogene|March 1, 2005
Stat3 regulates genes common to both wound healing and cancerDaniel J Dauer, Bernadette Ferraro, Lanxi Song, et al.
Cancer Research|October 19, 2005
Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cellsSangkil Nam, Donghwa Kim, Jin Q Cheng, et al.
Translational Oncology|May 30, 2019
Increasing Antitumor Activity of JAK Inhibitor by Simultaneous Blocking Multiple Survival Signaling Pathways in Human Ovarian CancerWei Wen, Ernest S Han, Thanh H Dellinger, et al.
Plos One|November 21, 2012
Spirooxindole derivative SOID-8 induces apoptosis associated with inhibition of JAK2/STAT3 signaling in melanoma cellsYan Tian, Sangkil Nam, Lucy Liu, et al.
Cancer Biology & Therapy|August 17, 2012
A novel 7-bromoindirubin with potent anticancer activity suppresses survival of human melanoma cells associated with inhibition of STAT3 and Akt signalingLucy Liu, Marina Kritsanida, Prokopios Magiatis, et al.
Biochemical Pharmacology|September 12, 2013
3-O-methylthespesilactam, a new small-molecule anticancer pan-JAK inhibitor against A2058 human melanoma cellsMin-Yi Li, Yan Tian, Li Shen, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2005
Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cellsSangkil Nam, Ralf Buettner, James Turkson, et al.
Cancer Research|May 2, 2013
Critical role of STAT3 in IL-6-mediated drug resistance in human neuroblastomaTasnim Ara, Rie Nakata, Michael A Sheard, et al.
Pageof 4